CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Public Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA) - 09/17/2026

Neutral
AI Analysis

Summary

The FDA will hold a hybrid public meeting on September 17, 2026, to discuss the reauthorization of Generic Drug User Fee Amendments (GDUFA).

Importance:2/10
Sentiment:
0.00
FDAGDUFAGeneric DrugsPublic MeetingRegulatory

Read the original article

Published by FDA Drugs (New Approvals & NDA) on September 1, 2026 4:28 PM

Read Original